Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center